• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy.比较经睫状体平坦部玻璃体切除术与玻璃体活检治疗迟发性眼内炎的结果。
J Glaucoma. 2022 Sep 1;31(9):744-750. doi: 10.1097/IJG.0000000000002056. Epub 2022 Jun 2.
2
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.迟发性水泡相关性眼内炎:临床特征及视力预后
Ophthalmology. 2002 May;109(5):985-91. doi: 10.1016/s0161-6420(02)00965-x.
3
[Clinical analysis of glaucoma bleb-associated endophthalmitis].[青光眼滤过泡相关性眼内炎的临床分析]
Zhonghua Yan Ke Za Zhi. 2011 Feb;47(2):114-21.
4
Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.眼内注射血管内皮生长因子抑制剂后的眼内炎:处理和视力结果。
Ophthalmology. 2018 Aug;125(8):1279-1286. doi: 10.1016/j.ophtha.2018.01.022. Epub 2018 Feb 21.
5
A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis.疑似感染性眼内炎病例的实践模式、微生物学产量和临床结果的九年分析。
Ophthalmol Retina. 2020 Jun;4(6):555-559. doi: 10.1016/j.oret.2020.03.009. Epub 2020 Mar 18.
6
Delayed-onset endophthalmitis associated with conjunctival filtering blebs.与结膜滤过泡相关的迟发性眼内炎。
Ophthalmology. 1997 May;104(5):746-52. doi: 10.1016/s0161-6420(97)30238-3.
7
VISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two.急性手术后和眼内注射后眼内炎早期玻璃体切除术和眼内抗生素的视觉结果:欧洲玻璃体视网膜学会眼内炎研究报告二。
Retina. 2021 Feb 1;41(2):423-430. doi: 10.1097/IAE.0000000000002856.
8
Endophthalmitis after filtering surgery with mitomycin.丝裂霉素滤过性手术后的眼内炎
Arch Ophthalmol. 1996 Aug;114(8):943-9. doi: 10.1001/archopht.1996.01100140151007.
9
INFECTIOUS ENDOPHTHALMITIS AFTER GLAUCOMA DRAINAGE IMPLANT SURGERY: Clinical Features, Microbial Spectrum, and Outcomes.青光眼引流植入手术后感染性眼内炎:临床特征、微生物谱及预后
Retina. 2017 Jun;37(6):1160-1167. doi: 10.1097/IAE.0000000000001329.
10
Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes.25G和20G玻璃体切割术后眼内炎:发病率及预后
Retina. 2008 Jan;28(1):138-42. doi: 10.1097/IAE.0b013e31815e9313.

引用本文的文献

1
Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery.青光眼滤过术后感染性眼内炎的临床分析
J Ophthalmic Inflamm Infect. 2024 Feb 29;14(1):11. doi: 10.1186/s12348-024-00391-4.
2
Endophthalmitis Associated With XEN Stent Implantation.与 XEN 支架植入相关的眼内炎。
Am J Ophthalmol. 2023 Sep;253:37-43. doi: 10.1016/j.ajo.2023.04.006. Epub 2023 Apr 13.

比较经睫状体平坦部玻璃体切除术与玻璃体活检治疗迟发性眼内炎的结果。

Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy.

机构信息

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens.

Department of Ophthalmology, University of Florida College of Medicine, Gainesville, FL.

出版信息

J Glaucoma. 2022 Sep 1;31(9):744-750. doi: 10.1097/IJG.0000000000002056. Epub 2022 Jun 2.

DOI:10.1097/IJG.0000000000002056
PMID:35654366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9437113/
Abstract

PRCIS

Bleb-related endophthalmitis (BRE) is a serious complication of glaucoma filtration surgery. The current study reports similar visual and intraocular pressure (IOP) outcomes in eyes treated with pars plana vitrectomy (PPV) compared with vitreous biopsy and injection of intravitreal antibiotics (TI).

PURPOSE

The purpose of this study was to investigate the isolated organisms, visual acuity (VA), and IOP outcomes associated with delayed-onset BRE in eyes treated with PPV versus TI.

PATIENTS AND METHODS

A retrospective chart review was conducted at the Bascom Palmer Eye Institute (Miami, Florida) and the University of Florida (Gainesville, FL) identifying patients treated for BRE with at least 1 month of follow-up from the inception of an electronic health record (2014 and 2011, respectively) through 2021. All patients had undergone bleb-forming glaucoma surgery at least 1 month before endophthalmitis diagnosis.

RESULTS

Thirty-nine eyes from 39 patients (33 from Bascom Palmer, 6 from University of Florida) were included. Trabeculectomy was performed in 34 of 39 eyes (87.2%). Streptococcus species (9 eyes, 23.1%) and Staphylococcus species (8 eyes, 20.5%) were the most common isolated organisms and were similar in both treatment groups ( P =0.49). Baseline VA was worse in the PPV group (logarithm of the minimum angle of resolution: 2.51 vs. 2.16, P =0.04), but VA at last follow-up was similar ( P =0.48) in both groups. After recovery from BRE, the average IOP in the PPV group was 15.1 mm Hg on 0.9 IOP-lowering medications compared with 12.6 mm Hg on 1.2 medications in the TI group (IOP: P =0.56; medications: P =0.80). Additional glaucoma surgery was performed in 44.4% of the PPV eyes and 16.7% of the TI eyes ( P =0.09).

CONCLUSION

In eyes with delayed-onset BRE, isolated organisms, visual outcomes, and IOP control were similar after initial PPV compared with TI.

摘要

PRCIS

青光眼滤过性手术相关眼内炎(BRE)是一种严重的并发症。本研究报告称,与玻璃体活检和玻璃体内注射抗生素(TI)相比,接受玻璃体切除术(PPV)治疗的眼睛具有相似的视力和眼内压(IOP)结果。

目的

本研究旨在研究与接受 PPV 治疗的眼睛中迟发性 BRE 相关的分离病原体、视力(VA)和 IOP 结果与接受 TI 治疗的眼睛相比。

患者和方法

在迈阿密的 Bascom Palmer 眼科研究所(佛罗里达州迈阿密)和佛罗里达州盖恩斯维尔的佛罗里达大学(佛罗里达州盖恩斯维尔)进行了回顾性图表审查,确定了至少在电子病历开始后 1 个月(分别为 2014 年和 2011 年)至 2021 年接受 BRE 治疗且随访时间至少 1 个月的患者。所有患者在诊断眼内炎前至少 1 个月接受了致滤过泡性青光眼手术。

结果

纳入了 39 名患者(33 名来自 Bascom Palmer,6 名来自佛罗里达大学)的 39 只眼。39 只眼中有 34 只(87.2%)行小梁切除术。最常见的分离病原体为链球菌属(9 只眼,23.1%)和葡萄球菌属(8 只眼,20.5%),且在两组中的比例相似(P=0.49)。PPV 组的基线 VA 较差(最小分辨角对数:2.51 与 2.16,P=0.04),但两组的最后随访时 VA 相似(P=0.48)。在 BRE 恢复后,PPV 组的平均 IOP 为 15.1mmHg,使用 0.9 种降眼压药物,而 TI 组为 12.6mmHg,使用 1.2 种药物(IOP:P=0.56;药物:P=0.80)。PPV 眼中有 44.4%和 TI 眼中有 16.7%需要进行额外的青光眼手术(P=0.09)。

结论

在迟发性 BRE 眼中,与 TI 相比,初始接受 PPV 治疗后,分离病原体、视力结果和 IOP 控制情况相似。